3 Questions: Cullen Buie on a new era for cell therapies (opens in new tab)

Genetic engineering and personalized cell therapies could transform health care. MIT Associate Professor Cullen Buie reflects on how his company, Kytopen, has grown and shifted focus in developing safer immunotherapies.